Inventor · disambiguated record
Shiming Ye
Also filed as: YE SHIMING
7 granted patents·12 pending applications·35 citations·filing 2002–2021
83Inventor score
Top patents by PatentIndex Score
19 records- 0192US10233258B2Bispecific binding proteins that bind CD40 and mesothelinABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Mar 19, 2019·16 cites·10 claims
- 0288US10023645B1Anti-CD40 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Jul 17, 2018·5 cites·11 claims
- 0384US6924109B2High-throughput transcriptome and functional validation analysisAGY THERAPEUTICS INC·Filed 2002·Granted Aug 2, 2005·12 cites·21 claims
- 0479US2022119542A1Anti-cd40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0578US10400041B2Nucleic acid molecules encoding anti-CD40 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·1 cites·20 claims
- 0677US10519243B2Anti-CD40 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Dec 31, 2019·1 cites·9 claims
- 0777US2021277137A1Anti-cd40 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0874US2021024642A1Anti-cd40 antibody and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0973US10844131B2Anti-CD40 antibodyABBVIE BIOTHERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·0 cites·9 claims
- 1072US10597460B2Anti-CD40 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2019·Granted Mar 24, 2020·0 cites·2 claims
- 1163US2020308290A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1257US2005123962A1Regulated nucleic acids in pathogenesis of alzheimer's diseaseAGY THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1356US2015010539A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1456US2005176030A1Regulated nucleic acids in pathogenesis of Alzheimer's DiseaseFiled 2004·Application pending·0 cites
- 1552US2005053936A1High-throughput transcriptome and functional validation analysisFiled 2002·Application pending·0 cites
- 1651US2017233481A1Anti-cd25 antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1750US2014377253A1Fc variantsABBVIE BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1848US2018251565A1Fc variantsABBVIE BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1946US2017342169A1Bispecific binding proteinsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shiming Ye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →